Compounds > rosiglitazone
Page last updated: 2024-08-25

rosiglitazone and Endometrioma

rosiglitazone has been researched along with Endometrioma in 9 studies

Research

Studies (9)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's6 (66.67)29.6817
2010's2 (22.22)24.3611
2020's1 (11.11)2.80

Authors

AuthorsStudies
Chen, M; Chen, Q; Liu, Q; Min, Q; Yu, X; Zhang, S; Zhuang, L1
Apgar, BS1
Lebovic, DI; Moravek, MB; Ward, EA1
Dhaliwal, LK; Dhawan, V; Saha, SC; Sharma, I1
Barañao, RI; Bilotas, M; Meresman, G; Olivares, C; Ricci, A1
Chao, VA; Pritts, EA; Sohn, SH; Taylor, RN; Waite, LL; Zhao, D1
Aytan, H; Aytan, P; Caliskan, AC; Demirturk, F; Koseoglu, DR2
Chai, DC; D'Hooghe, T; Fisseha, S; Lebovic, DI; Mueller, MD; Mwenda, JM; Santi, A1

Trials

1 trial(s) available for rosiglitazone and Endometrioma

ArticleYear
Thiazolidinediones as therapy for endometriosis: a case series.
    Gynecologic and obstetric investigation, 2009, Volume: 68, Issue:3

    Topics: Adult; Endometriosis; Female; Humans; Pain Measurement; Pelvic Pain; Prospective Studies; Rosiglitazone; Thiazolidinediones; Young Adult

2009

Other Studies

8 other study(ies) available for rosiglitazone and Endometrioma

ArticleYear
Rosiglitazone affects the progression of surgically‑induced endometriosis in a rat model.
    Molecular medicine reports, 2021, Volume: 23, Issue:1

    Topics: Animals; Caspase 3; Disease Models, Animal; Disease Progression; Endometriosis; Female; Gene Expression Regulation; Gynecologic Surgical Procedures; Methionine Adenosyltransferase; PPAR gamma; Rats; Rosiglitazone; Treatment Outcome; Vascular Endothelial Growth Factor A

2021
Challenges of fragmented care in long-term management of pelvic pain.
    The Journal of family practice, 2007, Volume: 56, Issue:3 Suppl Di

    Topics: Acetaminophen; Adult; Amines; Analgesics, Non-Narcotic; Analgesics, Opioid; Anti-Anxiety Agents; Chronic Disease; Continuity of Patient Care; Cyclohexanecarboxylic Acids; Diagnosis, Differential; Drug Therapy, Combination; Endometriosis; Female; Gabapentin; gamma-Aminobutyric Acid; Humans; Hydrocodone; Hypoglycemic Agents; Interdisciplinary Communication; Pelvic Pain; Risk Factors; Rosiglitazone; Substance-Related Disorders; Thiazolidinediones; Trazodone; Uterine Cervical Dysplasia; Uterine Cervical Neoplasms

2007
In vitro effects of peroxisome proliferator-activated receptor-γ ligands on gene expression in lipopolysaccharide-induced endometrial and endometriotic stromal cells.
    Fertility and sterility, 2011, Volume: 95, Issue:2

    Topics: Anti-Inflammatory Agents; Biopsy; Case-Control Studies; Cells, Cultured; Drug Evaluation, Preclinical; Endometriosis; Endometrium; Female; Gene Expression; Humans; Ligands; Lipopolysaccharides; PPAR gamma; Prostaglandin D2; Rosiglitazone; Stromal Cells; Thiazolidinediones; Uterine Diseases

2011
The inhibitory effect of celecoxib and rosiglitazone on experimental endometriosis.
    Fertility and sterility, 2011, Volume: 96, Issue:2

    Topics: Analysis of Variance; Animals; Antigens, CD34; Apoptosis; Celecoxib; Cell Proliferation; Cyclooxygenase 2 Inhibitors; Disease Models, Animal; Drug Therapy, Combination; Endometriosis; Female; Immunohistochemistry; In Situ Nick-End Labeling; Mice; Mice, Inbred BALB C; Neovascularization, Pathologic; Platelet Endothelial Cell Adhesion Molecule-1; PPAR gamma; Proliferating Cell Nuclear Antigen; Pyrazoles; Rosiglitazone; Sulfonamides; Thiazolidinediones; Time Factors; Uterus

2011
Peroxisome proliferator-activated receptor-gamma ligand inhibition of RANTES production by human endometriotic stromal cells is mediated through an upstream promoter element.
    Fertility and sterility, 2003, Volume: 80, Issue:2

    Topics: Base Sequence; Cells, Cultured; Chemokine CCL5; Endometriosis; Female; Humans; Ligands; Mutagenesis, Site-Directed; Promoter Regions, Genetic; Prostaglandin D2; Receptors, Cytoplasmic and Nuclear; Response Elements; Rosiglitazone; Stromal Cells; Thiazoles; Thiazolidinediones; Transcription Factors; Transfection

2003
Effect of peroxisome proliferator-activated receptor-gamma agonist rosiglitazone on the induction of endometriosis in an experimental rat model.
    Journal of the Society for Gynecologic Investigation, 2006, Volume: 13, Issue:1

    Topics: Animals; Disease Models, Animal; Endometriosis; Endometrium; Female; Hypoglycemic Agents; Inflammation; PPAR gamma; Rats; Rats, Wistar; Rosiglitazone; Thiazolidinediones

2006
PPAR-gamma receptor ligand induces regression of endometrial explants in baboons: a prospective, randomized, placebo- and drug-controlled study.
    Fertility and sterility, 2007, Volume: 88, Issue:4 Suppl

    Topics: Animals; Choristoma; Drug Evaluation, Preclinical; Endometriosis; Endometrium; Female; Ligands; Papio; Peritoneal Cavity; PPAR gamma; Prospective Studies; Random Allocation; Rosiglitazone; Thiazolidinediones

2007
Peroxisome proliferator-activated receptor-gamma agonist rosiglitazone reduces the size of experimental endometriosis in the rat model.
    The Australian & New Zealand journal of obstetrics & gynaecology, 2007, Volume: 47, Issue:4

    Topics: Animals; Disease Models, Animal; Endometriosis; Endometrium; Female; Macrophages; PPAR gamma; Rats; Rats, Wistar; Remission Induction; Rosiglitazone; Thiazolidinediones

2007